An W, Feola M, Levy M, Aluri S, Ruiz-Martinez M, Sridharan A
Elife. 2023; 12.
PMID: 38153418
PMC: 10754500.
DOI: 10.7554/eLife.83103.
Wang Q, Zennadi R
Antioxidants (Basel). 2021; 10(10).
PMID: 34679742
PMC: 8533084.
DOI: 10.3390/antiox10101608.
Feola M, Zamperone A, Moskop D, Chen H, Casu C, Lama D
Commun Biol. 2021; 4(1):517.
PMID: 33941818
PMC: 8093212.
DOI: 10.1038/s42003-021-02046-9.
Conran N, Embury S
Exp Biol Med (Maywood). 2021; 246(12):1458-1472.
PMID: 33794696
PMC: 8243211.
DOI: 10.1177/15353702211005392.
Conran N, Belcher J
Clin Hemorheol Microcirc. 2018; 68(2-3):263-299.
PMID: 29614637
PMC: 6314308.
DOI: 10.3233/CH-189012.
Intravascular hemolysis and the pathophysiology of sickle cell disease.
Kato G, Steinberg M, Gladwin M
J Clin Invest. 2017; 127(3):750-760.
PMID: 28248201
PMC: 5330745.
DOI: 10.1172/JCI89741.
Role of peroxiredoxin-2 in protecting RBCs from hydrogen peroxide-induced oxidative stress.
Nagababu E, Mohanty J, Friedman J, Rifkind J
Free Radic Res. 2012; 47(3):164-71.
PMID: 23215741
PMC: 5911927.
DOI: 10.3109/10715762.2012.756138.
SOD2 deficiency in hematopoietic cells in mice results in reduced red blood cell deformability and increased heme degradation.
Mohanty J, Nagababu E, Friedman J, Rifkind J
Exp Hematol. 2012; 41(3):316-21.
PMID: 23142655
PMC: 3741644.
DOI: 10.1016/j.exphem.2012.10.017.
Pro-oxidant and anti-oxidant status in patients of sickle cell anaemia.
Titus J, Chari S, Gupta M, Parekh N
Indian J Clin Biochem. 2012; 19(2):168-72.
PMID: 23105478
PMC: 3454190.
DOI: 10.1007/BF02894279.
A study of spectrin and lipid peroxidation of red blood cell membrane in thalassaemia carrier.
De Manisha , Banerjee D, Talukdar G, Bhattacharya D
Indian J Clin Biochem. 2012; 14(2):207-12.
PMID: 23105220
PMC: 3453575.
DOI: 10.1007/BF02867920.
Pathological basis of symptoms and crises in sickle cell disorder: implications for counseling and psychotherapy.
Ilesanmi O
Hematol Rep. 2011; 2(1):e2.
PMID: 22184515
PMC: 3222266.
DOI: 10.4081/hr.2010.e2.
The proteome of sickle cell disease: insights from exploratory proteomic profiling.
Yuditskaya S, Suffredini A, Kato G
Expert Rev Proteomics. 2010; 7(6):833-48.
PMID: 21142886
PMC: 3068560.
DOI: 10.1586/epr.10.88.
Role of the membrane in the formation of heme degradation products in red blood cells.
Nagababu E, Mohanty J, Bhamidipaty S, Ostera G, Rifkind J
Life Sci. 2009; 86(3-4):133-8.
PMID: 19958781
PMC: 2819203.
DOI: 10.1016/j.lfs.2009.11.015.
Oxidative stress in the regulation of normal and neoplastic hematopoiesis.
Ghaffari S
Antioxid Redox Signal. 2008; 10(11):1923-40.
PMID: 18707226
PMC: 2932538.
DOI: 10.1089/ars.2008.2142.
Heme degradation and oxidative stress in murine models for hemoglobinopathies: thalassemia, sickle cell disease and hemoglobin C disease.
Nagababu E, Fabry M, Nagel R, Rifkind J
Blood Cells Mol Dis. 2008; 41(1):60-6.
PMID: 18262448
PMC: 2497002.
DOI: 10.1016/j.bcmd.2007.12.003.
Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease.
Nath K, Grande J, Haggard J, Croatt A, Katusic Z, Solovey A
Am J Pathol. 2001; 158(3):893-903.
PMID: 11238038
PMC: 1850341.
DOI: 10.1016/S0002-9440(10)64037-0.
Removal of erythrocyte membrane iron in vivo ameliorates the pathobiology of murine thalassemia.
Browne P, Shalev O, Kuypers F, Brugnara C, Solovey A, Mohandas N
J Clin Invest. 1997; 100(6):1459-64.
PMID: 9294111
PMC: 508324.
DOI: 10.1172/JCI119666.
Red cell membrane remodeling in sickle cell anemia. Sequestration of membrane lipids and proteins in Heinz bodies.
Liu S, Yi S, Mehta J, Nichols P, Ballas S, Yacono P
J Clin Invest. 1996; 97(1):29-36.
PMID: 8550846
PMC: 507059.
DOI: 10.1172/JCI118402.
Sickle cell vasoocclusion: many issues and some answers.
Kaul D, Nagel R
Experientia. 1993; 49(1):5-15.
PMID: 8428611
DOI: 10.1007/BF01928783.
Band 3 and glycophorin are progressively aggregated in density-fractionated sickle and normal red blood cells. Evidence from rotational and lateral mobility studies.
Corbett J, Golan D
J Clin Invest. 1993; 91(1):208-17.
PMID: 8423219
PMC: 330016.
DOI: 10.1172/JCI116172.
